Clinical trial management system

Lindus Health Unveils Versatile "All-in-One Respiratory CRO" Offering Tailored to Respiratory Clinical Trials

Retrieved on: 
Tuesday, April 2, 2024
Sleep apnea, Pneumonia, MIT, Electronic data capture, Patient, Chronic obstructive pulmonary disease, Research, Pi, Health information management, EDC, Electronic health record, MD, Respiratory disease, Asthma, CTMS, Housing, Clinical trial management system, COPD, Data management, AptarGroup, Clinical data management, Fine chemical

Lindus Health has enrolled over 6,500 patients in respiratory clinical trials within the US, UK and Europe to date, showcasing their extensive resume of experience within this therapeutic area.

Key Points: 
  • Lindus Health has enrolled over 6,500 patients in respiratory clinical trials within the US, UK and Europe to date, showcasing their extensive resume of experience within this therapeutic area.
  • "We're thrilled to be launching a bespoke CRO offering to respiratory disease sponsors to mitigate the challenges faced in bringing essential respiratory therapies to market."
  • Deep regulatory and therapeutic area-specific expertise: Bringing together various research backgrounds, the Lindus Health team resumes exceptional expertise within respiratory clinical trials and the ever-changing regulatory landscapes of the US, UK, and EU.
  • Lindus Health is committed to leading successful respiratory research, providing a robust and efficient framework for clinical trials from inception to completion, and enhancing the experience for both sponsors and participants.

Lindus Health Introduces Comprehensive "All-In-One CRO" Package for CNS, Neurology, and Psychiatric Clinical Trials

Retrieved on: 
Tuesday, March 19, 2024
Principal, Neurology, Database, Psychiatry, MIT, Electronic data capture, Patient, CNS, Research, Health information management, EDC, Neuro, CTMS, Clinical trial management system, CMO, Data management, Clinical data management, Pharmaceutical industry

NEW YORK, March 19, 2024 /PRNewswire/ -- Lindus Health , the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched an all-in-one package of contract research organization (CRO) services tailored for CNS, neurology, and psychiatric clinical trials.

Key Points: 
  • NEW YORK, March 19, 2024 /PRNewswire/ -- Lindus Health , the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, has launched an all-in-one package of contract research organization (CRO) services tailored for CNS, neurology, and psychiatric clinical trials.
  • The "All-In-One CNS, Neurology and Psychiatry CRO" empowers sponsors within these therapeutic areas to execute more nimble and successful clinical trials.
  • Advanced patient recruitment strategies: Lindus Health supports neurology study sponsors in meeting their enrollment objectives efficiently through diverse recruitment tactics.
  • Lindus Health is dedicated to advancing CNS research, offering a robust solution for faster and more effective clinical trials while delivering exceptional clinical trial experiences for both sponsors and patients.

Calyx CTMS Select Delivers Robust Functionality for Small/Mid-sized Biopharma and CROs

Retrieved on: 
Monday, November 20, 2023
Clinical trial management system, Organization, CTMS, Clinical trial, Clinical data management, EDC, ChromeOS, Online shopping, Calyx

NOTTINGHAM, England and BILLERICA, Mass., Nov. 20, 2023 /PRNewswire/ -- Calyx, the eClinical and eRegulatory solutions and services provider relied on for solving complex data challenges in clinical research announces an offering for small and mid-sized (SMID) biopharmaceutical companies and CROs that delivers the reliability and global operational support of a proven Clinical Trial Management System (CTMS) with faster implementation times and at lower costs.

Key Points: 
  • CTMS Select is tailored to meet the needs, timelines and budgets of SMID organizations who don't need CTMS customization
    Calyx CTMS Select is a scalable, pre-configured, and validated solution with the rich features required for effective clinical trial management oversight and monitoring.
  • Based on Calyx's 25+ years of expertise supporting diverse trials, it is perfectly tailored to meet the needs, timelines, and budgets of SMID organizations that don't require CTMS customization.
  • Calyx CTMS Select can be implemented in as little as 6-8 weeks and includes out-of-the-box eTMF and EDC integrations and sophisticated features – such as comprehensive site payments – that are rarely included in solutions for smaller organizations.
  • Click here for more information on Calyx CTMS Select.

Calyx CTMS Select Delivers Robust Functionality for Small/Mid-sized Biopharma and CROs

Retrieved on: 
Monday, November 20, 2023
Clinical trial management system, Clinical data management, Clinical trial, ChromeOS, Organization, CTMS, EDC, Online shopping, Calyx

NOTTINGHAM, England and BILLERICA, Mass., Nov. 20, 2023 /PRNewswire/ -- Calyx, the eClinical and eRegulatory solutions and services provider relied on for solving complex data challenges in clinical research announces an offering for small and mid-sized (SMID) biopharmaceutical companies and CROs that delivers the reliability and global operational support of a proven Clinical Trial Management System (CTMS) with faster implementation times and at lower costs.

Key Points: 
  • Calyx CTMS Select is a scalable, pre-configured, and validated solution with the rich features required for effective clinical trial management oversight and monitoring.
  • Based on Calyx's 25+ years of expertise supporting diverse trials, it is perfectly tailored to meet the needs, timelines, and budgets of SMID organizations that don't require CTMS customization.
  • Calyx CTMS Select can be implemented in as little as 6-8 weeks and includes out-of-the-box eTMF and EDC integrations and sophisticated features – such as comprehensive site payments – that are rarely included in solutions for smaller organizations.
  • Click here for more information on Calyx CTMS Select.

Optimizing Study Execution in Obesity Clinical Trials: Considerations for Recruitment and Retention, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, August 3, 2023
Medical Affairs Bureau, Diet, Prevalence, Clinical trial management system, United States Army Medical Department Center and School, Recruitment, Clinical trial, Clinical research, Medpace, Lurie, Regulatory affairs, Disease, Nursing, Pharmaceutical industry, Medical device, Obesity

TORONTO, Aug. 3, 2023 /PRNewswire-PRWeb/ -- Obesity is a globally recognized health crisis. As awareness and the prevalence of this disease continue to grow, so does the urgency for effective treatment methods. Clinical trials are a crucial component of discovering and refining these interventions, but the management of obesity trials presents distinct challenges, particularly in the areas of recruitment and retention of participants.

Key Points: 
  • In this free webinar, learn the strategies for managing rapid enrollment in obesity clinical trials.
  • To address these issues and provide insights into optimizing study execution, a distinguished panel of experts from Medpace will lead an insightful webinar titled "Optimizing Study Execution in Obesity Clinical Trials: Considerations for Recruitment and Retention."
  • The session will be invaluable for professionals working within Clinical Affairs, Clinical Research, Clinical Pharmacology, Clinical Outsourcing, Clinical Operations, Regulatory Affairs and Medical Affairs.
  • Medpace and Xtalks have joined forces for this webinar to share knowledge and foster collaborative discussions.

Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery

Retrieved on: 
Tuesday, August 1, 2023
Partnership, Clinical data management, Clinical trial, Multimedia, Patient, Clario Tech, Sale, Clinical trial management system, CTMS, Acquisition, Risk, Title 21 CFR Part 11, Clinical, EDC, Fine chemical, Medical device, Online shopping

MIAMI, Aug. 1, 2023 /PRNewswire/ -- Sitero, a next-generation, site-focused CRO and a leading provider of clinical trial solutions, is thrilled to announce its recent acquisition of an advanced technology suite designed to manage the end-to-end clinical trial lifecycle.

Key Points: 
  • MIAMI, Aug. 1, 2023 /PRNewswire/ -- Sitero, a next-generation, site-focused CRO and a leading provider of clinical trial solutions, is thrilled to announce its recent acquisition of an advanced technology suite designed to manage the end-to-end clinical trial lifecycle.
  • The newly acquired eClinical technology suite will be integrated with Sitero's existing Mentor platform with plans to invest heavily in AI to further streamline the clinical trial process from start to finish.
  • "This acquisition expands our clinical offerings with a flexible and user-friendly suite of clinical technology solutions that we expect to further strengthen the foundation of our Mentor technology platform."
  • For more information about Sitero and its comprehensive suite of clinical trial solutions, please visit www.sitero.com or contact us at [email protected]
    View original content to download multimedia: https://www.prnewswire.com/news-releases/sitero-acquires-clarios-eclinic...

Sitero Acquires Clario's eClinical Technology Suite to Enhance Clinical Trial Delivery

Retrieved on: 
Tuesday, August 1, 2023
Partnership, Clinical data management, Clinical trial, Patient, Clario Tech, Sale, Clinical trial management system, CTMS, Acquisition, Risk, Title 21 CFR Part 11, Clinical, EDC, Fine chemical, Medical device

MIAMI, Aug. 1, 2023 /PRNewswire/ -- Sitero, a next-generation, site-focused CRO and a leading provider of clinical trial solutions, is thrilled to announce its recent acquisition of an advanced technology suite designed to manage the end-to-end clinical trial lifecycle.

Key Points: 
  • MIAMI, Aug. 1, 2023 /PRNewswire/ -- Sitero, a next-generation, site-focused CRO and a leading provider of clinical trial solutions, is thrilled to announce its recent acquisition of an advanced technology suite designed to manage the end-to-end clinical trial lifecycle.
  • The newly acquired eClinical technology suite will be integrated with Sitero's existing Mentor platform with plans to invest heavily in AI to further streamline the clinical trial process from start to finish.
  • "This acquisition expands our clinical offerings with a flexible and user-friendly suite of clinical technology solutions that we expect to further strengthen the foundation of our Mentor technology platform."
  • For more information about Sitero and its comprehensive suite of clinical trial solutions, please visit www.sitero.com or contact us at [email protected]

Digital Health: Embracing Human-Centered Design to Create Impactful Digital Experiences, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, June 29, 2023
Partnership, Digital health, Clinical trial management system, Royalties (brand management agency), Innovation, Thought, Organization, The X Factor Digital Experience, Patient, Engineering, Digital, Demand generation, Pharmaceutical industry, Medical device

TORONTO, June 29, 2023 /PRNewswire-PRWeb/ -- An upcoming free webinar in the field of digital health is set to take place. This webinar is focused on the importance and implementation of human-centered design in creating impactful digital experiences that patients truly appreciate. This event will feature industry-leading panelists in the pharmaceutical domain, discussing how organizations and companies can ensure their digital health solutions are not only feasible and viable but also desirable for patients.

Key Points: 
  • The featured speakers will discuss how to conduct qualitative interviews and ethnographic research to uncover user needs and create impactful digital experiences.
  • TORONTO, June 29, 2023 /PRNewswire-PRWeb/ -- An upcoming free webinar in the field of digital health is set to take place.
  • This webinar is focused on the importance and implementation of human-centered design in creating impactful digital experiences that patients truly appreciate.
  • The free webinar , titled "Digital Health: Embracing Human-Centered Design to Create Impactful Digital Experiences," will take place on Wednesday, July 19, 2023, at 1pm EDT (10am PDT).

Global eClinical Solutions Market Report 2023: Increased Government Grants to Support Clinical Trials Drives Growth

Retrieved on: 
Wednesday, June 28, 2023
Pharma, ECOA, Randomization, Clinical data management system, Clinical trial management system, Electronic trial master file, Electronic data capture, CTMS, CDMS, EDC, Speciality chemicals, Medical imaging, Pharmaceutical industry

Global eClinical Solutions Market, by Pharma and Biopharma Companies, by Region, 2019-2032 (USD Billion)

Key Points: 
  • Global eClinical Solutions Market, by Pharma and Biopharma Companies, by Region, 2019-2032 (USD Billion)
    8.2.1.
  • Global eClinical Solutions Market, by Electronic Clinical Outcome Assessment (ECOA), by Region, 2019-2032 (USD Billion)
    8.4.1.
  • Global eClinical Solutions Market, by Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), by Region, 2019-2032 (USD Billion)
    8.6.1.
  • Global eClinical Solutions Market, by Clinical Trial Management Systems (CTMS), by Region, 2019-2032 (USD Billion)
    8.9.1.

Chronic Kidney Disease: Breaking Barriers with Cardiovascular and Renal Integration in Clinical Trials, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Wednesday, June 7, 2023
Chronic kidney disease, Prevalence, Clinical trial management system, Cardiovascular disease, FACC, Clinical trial, Quality of life, Risk, History, Doctor of Philosophy, Thought, Army Medical Department (United States), Incidence, Patient, FASN, Mortality, Longevity, CKD, Conditional sentence, Pharmaceutical industry, MD, Medpace

TORONTO, June 7, 2023 /PRNewswire-PRWeb/ -- 21st century medicine and technology has seen exciting advancements at a pace and scale so remarkable that it exceeds the medical trajectory as compared to all of human history combined. This evolution, marked by preventative measures in healthcare, has improved the longevity and quality of life for patients, which also equates to a rising incidence and prevalence of chronic disease, especially chronic kidney disease (CKD).

Key Points: 
  • In this free webinar, learn about the historical exclusion of chronic kidney disease (CKD) from clinical trials and the considerations and reasons to increase the CKD population in clinical trials.
  • The featured speakers will discuss cardiorenal case studies to exemplify how cross collaboration and integration lead to overall clinical trial success.
  • Historically, however, those with chronic kidney disease have represented a population traditionally excluded from clinical trials, especially those in cardiovascular disease despite the improved understanding of its implications related to comorbid diseases.
  • Join this webinar to learn about integrated approaches to include patients with chronic kidney disease in cardiovascular clinical trials, benefiting both patients and improving disease burden worldwide.